In the midst of the pandemic, a blood testing company pivoted from their initial plans to focus on COVID-19 testing and have since raised 200 million dollars.
GoodListen © 2023
About
Privacy Policy
Terms of service
Support
Blog
Search Podcasts
Podcasts